ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
2.85
0.28 (10.89%)
At close: Aug 20, 2025, 3:59 PM
2.94
3.14%
Pre-market: Aug 21, 2025, 06:11 AM EDT
ImmunoPrecise Antibodies Revenue
ImmunoPrecise Antibodies reported an annual revenue of $24.52M, reflecting a 0.01% growth. For the quarter ending April 30, 2025, ImmunoPrecise Antibodies generated $6.98M in revenue.
Revenue (ttm)
24.52M
Revenue Growth
0.01%
Price / Sales Ratio
0.82
Revenue / Employee
340.56K
Employees
72
Market Cap
131.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Apr 30, 2025 | 24.52M | +0.01% |
| Apr 30, 2024 | 24.52M | +18.65% |
| Apr 30, 2023 | 20.66M | +6.72% |
| Apr 30, 2022 | 19.36M | +8.11% |
| Apr 30, 2021 | 17.91M | +27.41% |
| Apr 30, 2020 | 14.06M | +28.67% |
| Apr 30, 2019 | 10.93M | +100.81% |
| Apr 30, 2018 | 5.44M | +106.80% |
| Apr 30, 2017 | 2.63M | +38.77% |
| Apr 30, 2016 | 1.9M | +7.51% |
| Dec 31, 2014 | 1.76M | +Infinity% |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2010 | 0 | n/a |
| Dec 31, 2009 | 0 | n/a |
| Dec 31, 2008 | 0 | n/a |
| Dec 31, 2007 | 0 | n/a |
| Dec 31, 2006 | 0 | n/a |
| Dec 31, 2005 | 0 | n/a |
| Dec 31, 2004 | 0 | n/a |
| Dec 31, 2003 | 0 | n/a |
| Dec 31, 2002 | 0 | -100.00% |
| Dec 31, 2001 | 386 | +16.97% |
| Dec 31, 2000 | 330 | -95.65% |
| Dec 31, 1999 | 7.58K | -85.62% |
| Dec 31, 1998 | 52.73K | +90815.52% |
| Dec 31, 1997 | 58 | -99.11% |
| Dec 31, 1996 | 6.53K | n/a |